| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| T Harada, T Kumazaki, T Kigure, K Etori, S Tsuchid. Effect of adrenergic agents on urethral pressure and urethral compliance measurements in dog proximal urethra. The Journal of urology. vol 142. issue 1. 1989-07-25. PMID:2733102. |
the urethral closure pressure decreased after the administration of dopamine and haloperidol. |
1989-07-25 |
2023-08-11 |
dog |
| C R Oliveira, M C Lima, C A Carvalho, J E Leysen, A P Carvalh. Partition coefficients of dopamine antagonists in brain membranes and liposomes. Biochemical pharmacology. vol 38. issue 13. 1989-07-25. PMID:2735949. |
partition coefficients, kp of dopamine antagonists, spiperone, haloperidol, domperidone and pimozide were determined in caudate nucleus microsomal membranes and in liposomes from membrane lipids. |
1989-07-25 |
2023-08-11 |
Not clear |
| Y Imazu, K Kobayashi, T Shomor. [Difference in mechanism of action of sulpiride and haloperidol on dopamine brain turnover]. Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica. vol 90. issue 10. 1989-07-25. PMID:3251268. |
[difference in mechanism of action of sulpiride and haloperidol on dopamine brain turnover]. |
1989-07-25 |
2023-08-11 |
Not clear |
| C A Wilmot, A M Szczepani. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain. Brain research. vol 487. issue 2. 1989-07-18. PMID:2525063. |
effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-ht2) and dopamine (d2) receptors in the rat brain. |
1989-07-18 |
2023-08-11 |
rat |
| X T Hu, R Y Wan. Haloperidol and clozapine: differential effects on the sensitivity of caudate-putamen neurons to dopamine agonists and cholecystokinin following one month continuous treatment. Brain research. vol 486. issue 2. 1989-07-18. PMID:2786442. |
haloperidol and clozapine: differential effects on the sensitivity of caudate-putamen neurons to dopamine agonists and cholecystokinin following one month continuous treatment. |
1989-07-18 |
2023-08-11 |
rat |
| X T Hu, R Y Wan. Haloperidol and clozapine: differential effects on the sensitivity of caudate-putamen neurons to dopamine agonists and cholecystokinin following one month continuous treatment. Brain research. vol 486. issue 2. 1989-07-18. PMID:2786442. |
the effects of one month continuous treatment with either the typical antipsychotic drug (apd) haloperidol (hal) or atypical apd clozapine (cloz) on the responses of caudate-putamen (cpu) neurons to dopamine (da) d1 receptor agonist (+)skf-38393, d2 receptor agonist quinpirole and sulfated cholecystokinin octapeptide (cck-8s) were compared. |
1989-07-18 |
2023-08-11 |
rat |
| J D Salamone, R W Keller, M J Zigmond, E M Stricke. Behavioral activation in rats increases striatal dopamine metabolism measured by dialysis perfusion. Brain research. vol 487. issue 2. 1989-07-18. PMID:2786443. |
the dialysis perfusion method was used to study the effects of haloperidol, electrical brain stimulation, and behavioral activation on extracellular levels of dopamine metabolites in the rat striatum. |
1989-07-18 |
2023-08-11 |
rat |
| P J Fletche. Tryptamine impairs the acquisition of a one-way active avoidance task. Pharmacology, biochemistry, and behavior. vol 32. issue 1. 1989-07-17. PMID:2525258. |
the acquisition deficit induced by tryptamine may involve a direct stimulation of central 5-ht receptors since it was not induced by systemically administered 5-ht, was reversed by the 5-ht antagonists methysergide and metergoline, but was not affected by depletion of brain 5-ht, with pcpa, or by the dopamine antagonist haloperidol. |
1989-07-17 |
2023-08-11 |
rat |
| M Bijak, A Smiałowsk. Functional supersensitivity of the hippocampal dopaminergic system after prolonged treatment with haloperidol. Pharmacology, biochemistry, and behavior. vol 32. issue 1. 1989-07-17. PMID:2567526. |
the excitatory effects of dopamine and ly 171555 were blocked by sulpiride and haloperidol. |
1989-07-17 |
2023-08-11 |
Not clear |
| M Bijak, A Smiałowsk. Functional supersensitivity of the hippocampal dopaminergic system after prolonged treatment with haloperidol. Pharmacology, biochemistry, and behavior. vol 32. issue 1. 1989-07-17. PMID:2567526. |
prolonged administration of haloperidol potentiated the excitatory reaction of dopamine and apomorphine; however, even a single dose of the neuroleptic enhanced the dopamine-induced effect. |
1989-07-17 |
2023-08-11 |
Not clear |
| M Bijak, A Smiałowsk. Functional supersensitivity of the hippocampal dopaminergic system after prolonged treatment with haloperidol. Pharmacology, biochemistry, and behavior. vol 32. issue 1. 1989-07-17. PMID:2567526. |
the present findings indicate that long-term administration of haloperidol results in an increased sensitivity of hippocampal neurons to the mixed dopamine agonists, dopamine and apomorphine, but not to selective stimulation of the d2 receptor. |
1989-07-17 |
2023-08-11 |
Not clear |
| A I Smith, C A Wallace, I J Clarke, J W Funde. Dopaminergic agents differentially regulate both processing and content of alpha-N-acetylated endorphin and alpha-MSH in the ovine pituitary intermediate lobe. Neuroendocrinology. vol 49. issue 5. 1989-07-12. PMID:2566941. |
to determine if these effects reflect the loss of descending dopaminergic neuronal input to the il, we have chronically treated two groups (n = 4 per group) of normal sheep with the dopamine antagonist haloperidol or the dopamine agonist bromocriptine; a group of hpd sheep were also treated with bromocriptine. |
1989-07-12 |
2023-08-11 |
Not clear |
| R Sandyk, G Awerbuc. Recurrence of complex motor and vocal tics in an elderly woman responsive to opiates. The International journal of neuroscience. vol 44. issue 3-4. 1989-07-07. PMID:2722417. |
this report implicates derangement in the activity of the endogenous opioid system in the pathophysiology of tourette's syndrome, and suggest that opiates may be prescribed in the therapy of ts patients otherwise recalcitrant to administration of haloperidol or other dopamine blocking agents. |
1989-07-07 |
2023-08-11 |
Not clear |
| P Salvati, G P Bondiolotti, C Caccia, F Vaghi, G Bianch. Mechanism of the antihypertensive effect of FCE 22716, a new ergoline derivative, in the spontaneously hypertensive rat. Pharmacology. vol 38. issue 2. 1989-07-07. PMID:2727050. |
haloperidol, a dopamine antagonist that crosses the blood-brain barrier, also antagonized fce 22716 activity. |
1989-07-07 |
2023-08-11 |
rat |
| K Yamaguchi, H Ham. Facilitatory role of central dopamine in the osmotic release of vasopressin. Brain research. vol 481. issue 2. 1989-06-30. PMID:2720392. |
injection of the dopamine antagonist haloperidol (0.15 mumol) blocked increases in plasma vasopressin (avp) and arterial pressure caused by i.c.v. |
1989-06-30 |
2023-08-11 |
rat |
| G Kövér, M Fekete, H Tost, K Szemeréd. The combined effects of dopamine (DA) and the DA antagonists EGYT-2509, chlorpromazine and haloperidol on the kidney function. Acta physiologica Hungarica. vol 72. issue 3-4. 1989-06-29. PMID:3250211. |
the combined effects of dopamine (da) and the da antagonists egyt-2509, chlorpromazine and haloperidol on the kidney function. |
1989-06-29 |
2023-08-11 |
Not clear |
| K Yamada, N Matsuo, M Nagashima, M Kumagai, T Furukaw. Dopamine receptor blocking action of a dibenzothiepin derivative isofloxythepin in rats. Clinical and experimental pharmacology & physiology. vol 16. issue 2. 1989-06-22. PMID:2565774. |
the results suggest that isofloxythepin, as well as haloperidol, blocks the action of the dopamine d2-receptors in the striatum, nucleus accumbens and pituitary. |
1989-06-22 |
2023-08-11 |
rat |
| Y Itzhak, S Alerhan. Differential regulation of sigma and PCP receptors after chronic administration of haloperidol and phencyclidine in mice. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 3. issue 7. 1989-06-15. PMID:2541039. |
the following radiolabeled ligands were used to assess binding to the various receptor subtypes: [3h]-1-[1-[3-hydroxyphenyl)cyclohexyl]piperidine ([3h]pcp-3-oh; sigma p and pcp sites), [3h]thienyl-phencyclidine ([3h]tcp; pcp site), (+)-[3h]skf 10,047 (sigma p and sigma h sites), and [3h]haloperidol (sigma h and d-2 dopamine receptors). |
1989-06-15 |
2023-08-11 |
mouse |
| Y Itzhak, S Alerhan. Differential regulation of sigma and PCP receptors after chronic administration of haloperidol and phencyclidine in mice. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 3. issue 7. 1989-06-15. PMID:2541039. |
however, similar treatment with haloperidol (4 mg.kg-1.day-1) induced: 1) complete elimination of the binding to sigma h sites, 2) up-regulation of d-2 dopamine receptors, and 3) no change in sigma p and pcp receptor binding after 14 or 21 days of treatment. |
1989-06-15 |
2023-08-11 |
mouse |
| W Zhang, H Tilson, M K Stachowiak, J S Hon. Repeated haloperidol administration changes basal release of striatal dopamine and subsequent response to haloperidol challenge. Brain research. vol 484. issue 1-2. 1989-06-15. PMID:2713698. |
repeated haloperidol administration changes basal release of striatal dopamine and subsequent response to haloperidol challenge. |
1989-06-15 |
2023-08-11 |
rat |